Get started
MOCHIDA PHARM.MOCHIDA PHARM.MOCHIDA PHARM.

MOCHIDA PHARM.

No trades
See on Supercharts
Overview
Financials News Discussions Seasonals

MFY chart


Full chart

MFY upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪621.41 M‬ EUR
Dividend yield (indicated)
2.69%
Price to earnings Ratio (TTM)
18.1
Basic EPS (TTM)
1.0 EUR
Net income (FY)
‪35.03 M‬ EUR
Revenue (FY)
‪647.95 M‬ EUR
Shares float
‪17.86 M‬
Beta (1Y)
0.67

About MOCHIDA PHARMACEUTICAL CO


Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
mochida.co.jp
Headquarters
Tokyo
Founded
1913
ISIN
JP3922800002
FIGI
BBG000C4SM44
Mochida Pharmaceutical Co. Ltd. engages in the research, development, manufacturing and sale of pharmaceuticals, healthcare products, and medical equipment. It operates through following business divisions: Pharmaceuticals and Healthcare Products. The Pharmaceuticals division conducts research and development for medical needs. The Healthcare Products division manufactures and sells cosmetic and medicated products. It also manufactures and sells prescription drugs for cardiovascular, obstetrics and gynecology, dermatology, emergency and psychiatric ailments. The company was founded by Ryokichi Mochida in February 1913 and is headquartered in Tokyo, Japan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

MFY news



Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as MFY.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MOCHIDA PHARM. stocks are traded under the ticker MFY.
MFY reached its all-time high on Mar 7, 2019 with the price of 47.0 EUR, and its all-time low was 9.8 EUR and was reached on Nov 18, 2002. View more price dynamics on MFY chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track MOCHIDA PHARM. financials in yearly and quarterly reports right on TradingView.
MOCHIDA PHARM. is going to release the next earnings report on Aug 1, 2025. Keep track of upcoming events with our Earnings Calendar.
MFY net income for the last quarter is ‪492.93 K‬ EUR, while the quarter before that showed ‪17.08 M‬ EUR of net income which accounts for −97.11% change. Track more MOCHIDA PHARM. financial stats to get the full picture.
MOCHIDA PHARM. dividend yield was 2.52% in 2024, and payout ratio reached 49.89%. The year before the numbers were 2.48% and 63.10% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MOCHIDA PHARM. EBITDA is ‪68.19 M‬ EUR, and current EBITDA margin is 10.52%. See more stats in MOCHIDA PHARM. financial statements.
Like other stocks, MFY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MOCHIDA PHARM. stock right from TradingView charts — choose your broker and connect to your account.